Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteins

Bioorg Med Chem Lett. 2024 Jul 15:107:129779. doi: 10.1016/j.bmcl.2024.129779. Epub 2024 May 9.

Abstract

Targeted protein degradation is mediated by small molecules that induce or stabilize protein-protein interactions between targets and the ubiquitin-proteasome machinery. Currently, there remains a need to expand the repertoire of viable E3 ligases available for hijacking. Notably, covalent chemistry has been employed to engage a handful of E3 ligases, including DCAF11. Here, we disclose a covalent PROTAC that enables DCAF11-dependent degradation, featuring a cyanoacrylamide warhead. Our findings underscore DCAF11 as an interesting candidate with a capacity to accommodate diverse electrophilic chemistries compatible with targeted protein degradation.

Keywords: Cyanoacrylamide-based PROTACs; DCAF11; Targeted protein degradation.

MeSH terms

  • Acrylamides* / chemical synthesis
  • Acrylamides* / chemistry
  • Acrylamides* / pharmacology
  • Drug Discovery
  • Humans
  • Molecular Structure
  • Proteolysis / drug effects
  • Structure-Activity Relationship
  • Ubiquitin-Activating Enzymes / antagonists & inhibitors
  • Ubiquitin-Activating Enzymes / metabolism

Substances

  • Acrylamides
  • Ubiquitin-Activating Enzymes